-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
| Significant progress in the frontier of heart transplantation |
| The first domestic animal heart warm blood transfer was successful |
| The longest storage time of the heart is expected to exceed 12 hours |
Suzhou, July 19th (Reporter Yan Su, Correspondent Zhang Weimin Xia Jing) On the 19th, the reporter learned from Suzhou High-tech Zone that a warm blood transfer platform developed by Suzhou Xinqing Medical Technology Co.
, Ltd.
, a company in the district, and Wuhan Union Hospital jointly developed.
The successful experiment completed the first domestic animal donor heart warm blood transport
.
This technology is another major breakthrough in the frontier field of heart transplantation in China.
The longest preservation time of the heart is expected to exceed 12 hours, which is about 2 times longer than the commonly used cold ischemic preservation time in China
There are 13.
7 million heart failure patients in China, and 600,000 patients with end-stage heart failure
.
From 2015 to 2018, 35 heart transplant centers across the country only completed more than 1,500 heart transplants
.
After tackling key problems, the warm blood transfer platform jointly developed by Xinqing Medical and Wuhan Union Hospital has broken through the technical bottleneck of domestic donor heart preservation
.
Compared with cold ischemia protection, this set of platforms can establish extracorporeal circulation for the donor heart, allowing the donor heart to maintain a "working state" during transportation, and realize the heart transportation under the state of oxygenated blood supply, which can greatly reduce the heart rate.
The degree of damage
In this medical experiment, Professor Li Ping from the Department of Cardiovascular Surgery of Wuhan Union Medical College Hospital and the team of engineers from Xinqing Medical, jointly arrested the heart of the medical sheep at the Taizhou Animal Center in order to connect with the warm blood transfer equipment and successfully passed the autologous Blood perfusion realizes extracorporeal rebound
.
All physiological indexes of the sheep's heart after the start of rebound were normal
.
Sheep, sheep, sheep
Dong Nianguo, director of the Department of Cardiovascular Surgery of Wuhan Union Medical College Hospital, introduced that the success of this experiment has accumulated valuable practical experience for the R&D team, and successfully verified the feasibility of the principle and the stability of the equipment operation, which means that China’s first self-developed temperature The blood transfer platform is only "one step away" from going to the clinic
.
It is reported that there is currently only one similar technology in the world, and it can only be implemented in the country
.
